Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide

Koekkoek, J.A.F.; Dirven, L.; Heimans, J.J.; Postma, T.J.; Vos, M.J.; Reijneveld, J.C.; Taphoorn, M.J.B. (2016)

Article / Letter to editor

• Seizures
• Chemotherapy
• Temozolomide
• Primary brain tumor
• Glioma

• All authors: Koekkoek, J.A.F.; Dirven, L.; Heimans, J.J.; Postma, T.J.; Vos, M.J.; Reijneveld, J.C.; Taphoorn, M.J.B.
• Date: 2016-01-31
• Journal: Journal of Neuro-Oncology
• Volume: 126
• Issue: 2
• Pages: 347 - 354
• DOI: doi:10.1007/s11060-015-1975-y